CoFlo Medical, Inc. — Form D
CoFlo Medical, Inc. of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-28. The offering totals $6.0M, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-11-28
- Form: D
- Accession: 0002098562-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $500K
- Remaining: $5.5M
- Investors: 1
- Date of first sale: 2025-11-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-565277
Issuer
- Name: CoFlo Medical, Inc.
- CIK: 0002098562
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 135 Mississippi Street, San Francisco, CA, 94107
- Phone: 650-289-8394
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Matthew Goldman | Director | San Francisco, CA |
| Simon Rufer | Director | San Francisco, CA |
| Kripa Varanasi | Director | MALDEN, MA |
| Vishnu Jayaprakash | Executive Officer | San Francisco, CA |
| Simon Rufer | Executive Officer | San Francisco, CA |
More